Inhibition of NLRP3 inflammasome contributes to paclitaxel efficacy in triple negative breast cancer treatmentLiliana-Roxana Balahura(University of Bucharest), Sorina Dinescu(University of Bucharest)Scientific ReportsOctober 21, 202410.1038/s41598-024-75805-3Cited by 17SaveCiteExport RISWatch citationsRelated PapersCellulose Nanofiber-Based Hydrogels Embedding 5-FU Promote Pyroptosis Activation in Breast Cancer Cells and Support Human Adipose-Derived Stem Cell Proliferation, Opening New Perspectives for Breast Tissue Engineering|Pharmaceutics|2021|41Implantable Polymer Scaffolds Loaded with Paclitaxel–Cyclodextrin Complexes for Post-Breast Cancer Tissue Reconstruction|Polymers|2025|5